BSEInsider Trading / SAST23h ago · 24 Sept 2026, 07:14 pm

Closure of Trading Window

Rekvina Laboratories Ltd · 526075

✦ AI Summary

Rekvina Laboratories Ltd has announced the closure of its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Rekvina Laboratories Ltd - 526075 - Closure of Trading Window

Attachments (1)

📄

9770971f-1f8b-47be-b331-66314a40154f.pdf

pdf

Download →
View document text
Date: 24.09.2026 The Manager Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400001. BSE Script Code: 526075 Subject: Intimation of Closure of Trading Window Dear Sir/Madam, This is to inform you that pursuant to the “Code of Fair Disclosure ( Including determination of Legitimate Purpose), Internal procedures and conduct for Regulating, Monitoring and Reporting of Trading by Designated Person(s)” of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading window for dealing in securities of the Company by Designated Persons and their Immediate relatives will remain closed with effect from, October 01, 2026 until 48 hours after the declaration of Financial Results by the Company for the Quarter and Half Year ended on September 30, 2026. The date of Board Meeting of the Company for review and approval of the Financial Results for the Quarter and Half Year ended on September 30, 2026 will be intimated in due course. We request you to kindly take the same on your record and acknowledge. Thanking You Yours Faithfully For Rekvina Laboratories Limited Surbhit Mukesh Shah Director DIN: 01993300 CIN: L24231GJ1988PLC01145 Regd. Office: 3rd floor 5 Laxmi Society, B/h Baroda Heart Institute, O.P. Road, Vadodara – 390007 Email Id: info@rekvinalaboratories.com, rekvinalimited@gmail.com Cont. No.: 0265-2362966